Search research articles
Contact Us
Filters
Showing results (231-240 of 441) with videos related to
Page
of 45
Sort By:
Ultrasound in Medicine & Biology
|
July 22, 2011
Noninvasive in vivo liver fibrosis evaluation using supersonic shear imaging: a clinical study on 113 hepatitis C virus patients
Eric Bavu, Jean-Luc Gennisson, Mathieu Couade, et al.
Alcoholism, Clinical and Experimental Research
|
March 13, 2012
Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers
Jean-Baptiste Trabut, Véronique Thépot, Bertrand Nalpas, et al.
Hepatology (Baltimore, Md.)
|
March 29, 2012
Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: a relevant ex vivo model of liver infection
Sylvie Lagaye, Hong Shen, Bertrand Saunier, et al.
Medical Oncology (Northwood, London, England)
|
March 20, 2012
Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib
Olivier Mir, Romain Coriat, Pascaline Boudou-Rouquette, et al.
Transplantation
|
November 10, 2005
Efficacy and safety of adefovir dipivoxil in kidney recipients, hemodialysis patients, and patients with renal insufficiency
Hélène Fontaine, Anaïs Vallet-Pichard, Marie-Laure Chaix, et al.
Plos One
|
June 6, 2012
Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma
Olivier Mir, Romain Coriat, Benoit Blanchet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 6, 2019
Not Achieving Sustained Viral Eradication of Hepatitis C Virus After Treatment Leads to Worsening Patient-reported Outcomes
Zobair M Younossi, Maria Stepanova, Ira Jacobson, et al.
EMBO Molecular Medicine
|
May 4, 2016
Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post-translational modification: prospective placebo-controlled clinical studies
Jérémie Decalf, Kristin V Tarbell, Armanda Casrouge, et al.
Journal of Viral Hepatitis
|
December 18, 2022
Performance of algorithms for identifying patients with chronic hepatitis B or C infection in the french health insurance claims databases using the ANRS CO22 HEPATHER cohort
Laurent Lam, Hélène Fontaine, Nathanael Lapidus, et al.
Transplantation
|
September 24, 2004
Histopathologic efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C
Helene Fontaine, Anais Vallet-Pichard, Claudia Equi-Andrade, et al.
Page
of 45
Search research articles
Search
Showing results (231-240 of 441) with videos related to
Sort By:
Page
of 45
Ultrasound in Medicine & Biology
|
July 22, 2011
Noninvasive in vivo liver fibrosis evaluation using supersonic shear imaging: a clinical study on 113 hepatitis C virus patients
Eric Bavu, Jean-Luc Gennisson, Mathieu Couade, et al.
Alcoholism, Clinical and Experimental Research
|
March 13, 2012
Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers
Jean-Baptiste Trabut, Véronique Thépot, Bertrand Nalpas, et al.
Hepatology (Baltimore, Md.)
|
March 29, 2012
Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: a relevant ex vivo model of liver infection
Sylvie Lagaye, Hong Shen, Bertrand Saunier, et al.
Medical Oncology (Northwood, London, England)
|
March 20, 2012
Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib
Olivier Mir, Romain Coriat, Pascaline Boudou-Rouquette, et al.
Transplantation
|
November 10, 2005
Efficacy and safety of adefovir dipivoxil in kidney recipients, hemodialysis patients, and patients with renal insufficiency
Hélène Fontaine, Anaïs Vallet-Pichard, Marie-Laure Chaix, et al.
Plos One
|
June 6, 2012
Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma
Olivier Mir, Romain Coriat, Benoit Blanchet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 6, 2019
Not Achieving Sustained Viral Eradication of Hepatitis C Virus After Treatment Leads to Worsening Patient-reported Outcomes
Zobair M Younossi, Maria Stepanova, Ira Jacobson, et al.
EMBO Molecular Medicine
|
May 4, 2016
Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post-translational modification: prospective placebo-controlled clinical studies
Jérémie Decalf, Kristin V Tarbell, Armanda Casrouge, et al.
Journal of Viral Hepatitis
|
December 18, 2022
Performance of algorithms for identifying patients with chronic hepatitis B or C infection in the french health insurance claims databases using the ANRS CO22 HEPATHER cohort
Laurent Lam, Hélène Fontaine, Nathanael Lapidus, et al.
Transplantation
|
September 24, 2004
Histopathologic efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C
Helene Fontaine, Anais Vallet-Pichard, Claudia Equi-Andrade, et al.
Page
of 45